Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)
1 clinical trials · Condition
◉ Watch Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)
| Record | Firm | Date |
|---|---|---|
| Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2 (NCT03338348) | University of Ulm | 2018-04-19 |
Track Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2) automatically
Every clearance here is in the API, with alerts when new ones post.